IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CLBT

Balance Sheet

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022
Cash & Equivalents179.22106.96110.5091.69
Short-term Investments146.9171.6357.6132.44
Accounts Receivable93.130.130.1166.75
Inventory9.548.7810.828.12
Total Current Assets606.11414.75337.41233.64
Property, Plant & Equipment19.9615.8115.8117.77
Goodwill28.7126.8326.8326.83
Intangible Assets10.249.819.6217.95
Total Non-current Assets181.32141.8388.4991.20
Total Assets787.43556.58425.89324.84
Accounts Payable--42.2635.6247.45
Total Current Liabilities309.97237.23204.51172.87
Total Non-current Liabilities69.04359.51203.83127.91
Total Liabilities379.01596.74408.34300.78
Retained Earnings(127.99)22.96126.29167.07
Total Stockholder Equity408.41(40.16)17.5624.06
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022
Total Revenue220.832.4597.8870.39
Cost of Revenue35.1729.5325.4424.08
Gross Profit185.66155.77122.48100.88
Research & Development55.8946.8942.1839.25
Selling, General & Admin25.6322.7721.1921.02
Total Operating Expenses158.97134.04117.72108.42
Operating Income26.6921.734.76(7.54)
Pretax Income40.12(91.34)(70.07)87.32
Tax Provision3.243.842.89(1.31)
Net Income36.88(95.18)(72.95)88.64
Basic EPS0.15(0.48)(0.37)0.47
Diluted EPS0.15(0.48)(0.37)0.44
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022
Operating Cash Flow53.4624.5529.05(14.61)
Capital Expenditures5.953.571.893.88
Free Cash Flow*47.5120.9927.16(18.49)
Investing Cash Flow(85.93)(114.86)(14.81)(41.99)
Financing Cash Flow17.458.398.424.69
← Scroll for more columns →

* Derived from reported values